
### [MONDO:0017666](http://purl.obolibrary.org/obo/MONDO_0017666)
**Label:** diffuse palmoplantar keratoderma

**Subclasses:** [MONDO:0020093](http://purl.obolibrary.org/obo/MONDO_0020093) (autosomal dominant isolated diffuse palmoplantar keratoderma), [MONDO:0020094](http://purl.obolibrary.org/obo/MONDO_0020094) (autosomal dominant disease with diffuse palmoplantar keratoderma as a major feature), [MONDO:0006588](http://purl.obolibrary.org/obo/MONDO_0006588) (nonepidermolytic palmoplantar keratoderma), [MONDO:0017667](http://purl.obolibrary.org/obo/MONDO_0017667) (isolated diffuse palmoplantar keratoderma), [MONDO:0020096](http://purl.obolibrary.org/obo/MONDO_0020096) (autosomal recessive isolated diffuse palmoplantar keratoderma), [MONDO:0017851](http://purl.obolibrary.org/obo/MONDO_0017851) (erythrokeratodermia variabilis), [MONDO:0019014](http://purl.obolibrary.org/obo/MONDO_0019014) (mutilating palmoplantar keratoderma with periorificial keratotic plaques), [MONDO:0018781](http://purl.obolibrary.org/obo/MONDO_0018781) (KID syndrome), [MONDO:0017671](http://purl.obolibrary.org/obo/MONDO_0017671) (autosomal recessive disease with diffuse palmoplantar keratoderma as a major feature), [MONDO:0017670](http://purl.obolibrary.org/obo/MONDO_0017670) (autosomal dominant diffuse mutilating palmoplantar keratoderma), [MONDO:0017669](http://purl.obolibrary.org/obo/MONDO_0017669) (disease with diffuse palmoplantar keratoderma as a major feature), 

**Corr. equiv. classes:** [Orphanet:98352](http://www.orpha.net/ORDO/Orphanet_98352), [OMIM:133200](http://purl.obolibrary.org/obo/OMIM_133200), [Orphanet:307773](http://www.orpha.net/ORDO/Orphanet_307773), [Orphanet:307148](http://www.orpha.net/ORDO/Orphanet_307148), [Orphanet:307711](http://www.orpha.net/ORDO/Orphanet_307711), [Orphanet:307804](http://www.orpha.net/ORDO/Orphanet_307804), [Orphanet:317](http://www.orpha.net/ORDO/Orphanet_317), [Orphanet:316](http://www.orpha.net/ORDO/Orphanet_316), [Orphanet:98349](http://www.orpha.net/ORDO/Orphanet_98349), [Orphanet:659](http://www.orpha.net/ORDO/Orphanet_659), [Orphanet:98356](http://www.orpha.net/ORDO/Orphanet_98356), [Orphanet:477](http://www.orpha.net/ORDO/Orphanet_477), [Orphanet:2337](http://www.orpha.net/ORDO/Orphanet_2337), 

**Class expressions from DL-Learner:**

- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 64.87%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 60.11%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 58.76%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 56.50%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 54.59%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 53.18%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 48.72%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 48.10%
- [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 39.31%
- [HP:0000962](http://purl.obolibrary.org/obo/HP_0000962) (Hyperkeratosis) 33.79%
- [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 31.15%
- [HP:0001072](http://purl.obolibrary.org/obo/HP_0001072) (Thickened skin) 30.36%
- [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 29.35%
- [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 26.82%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 25.76%


